| 标题 |
Abstract CT301: SHR-A1811 ± adebrelimab as first-line (1L) treatment for advanced HER2-mutant NSCLC: A randomized phase 2 cohort from a phase 1b/2 study |
| 网址 | |
| DOI |
10.1158/1538-7445.AM2026-CT301
doi
|
| 其它 | 想要这个对应的幻灯。 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)